{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tofacitinib+10+mg+BID", "query": { "intervention": "Tofacitinib 10 mg BID" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 49, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tofacitinib+10+mg+BID&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-28T14:14:28.602Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01710046", "title": "Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "(CP-6890,550) Tofacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "(CP-690,550) Tofacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2013-03", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-04-13", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 5, "location_summary": "Los Angeles, California • Tampa, Florida • Dallas, Texas + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Dallas", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01710046" }, { "nct_id": "NCT01465763", "title": "A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "tofacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 614, "start_date": "2012-04", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2016-06-07", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 71, "location_summary": "Mobile, Alabama • La Jolla, California • Los Angeles, California + 29 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01465763" }, { "nct_id": "NCT01059864", "title": "Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "CP-690,550", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Atorvastatin Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2010-02", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2012-12-13", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01059864" }, { "nct_id": "NCT00550446", "title": "A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Adalimumab", "type": "DRUG" }, { "name": "CP-690,550", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 386, "start_date": "2007-09", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2013-01-03", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 22, "location_summary": "Mesa, Arizona • Little Rock, Arkansas • Northridge, California + 17 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Northridge", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00550446" }, { "nct_id": "NCT01831466", "title": "Tofacitinib Ointment For Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis Vulgaris", "Psoriasis" ], "interventions": [ { "name": "tofacitinib ointment 20 mg/g", "type": "DRUG" }, { "name": "tofacitinib ointment 10 mg/g", "type": "DRUG" }, { "name": "placebo ointment (vehicle)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 476, "start_date": "2013-05", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2015-11-25", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 29, "location_summary": "Hot Springs, Arkansas • Bakersfield, California • Irvine, California + 22 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01831466" }, { "nct_id": "NCT01164579", "title": "Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Tasocitinib plus Methotrexate", "type": "DRUG" }, { "name": "Tofacitinib plus placebo methotrexate", "type": "DRUG" }, { "name": "Placebo tofacitinib plus Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 109, "start_date": "2010-10", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-04-22", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 8, "location_summary": "Gilbert, Arizona • Huntington Beach, California • Upland, California + 5 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Ormond Beach", "state": "Florida" }, { "city": "Pinellas Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01164579" }, { "nct_id": "NCT01786668", "title": "Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Tofacitinib 2 mg", "type": "DRUG" }, { "name": "Tofacitinib 5 mg", "type": "DRUG" }, { "name": "Tofacitinib 10 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 208, "start_date": "2013-04", "completion_date": "2015-03", "has_results": true, "last_update_posted_date": "2016-06-10", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 22, "location_summary": "Indian Wells, California • Palm Desert, California • Clearwater, Florida + 15 more", "locations": [ { "city": "Indian Wells", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Ormond Beach", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01786668" }, { "nct_id": "NCT06095128", "title": "A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Vedolizumab", "type": "DRUG" }, { "name": "Tofacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2024-06-12", "completion_date": "2027-07-09", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 37, "location_summary": "Dothan, Alabama • Sun City, Arizona • Los Angeles, California + 33 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06095128" }, { "nct_id": "NCT01359150", "title": "A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "CP-690,550", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 223, "start_date": "2011-09", "completion_date": "2012-02", "has_results": true, "last_update_posted_date": "2013-03-29", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 51, "location_summary": "Gilbert, Arizona • Paradise Valley, Arizona • Jonesboro, Arkansas + 45 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fair Oaks", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01359150" }, { "nct_id": "NCT03681275", "title": "Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diaphragm Injury" ], "interventions": [ { "name": "Tofacitinib 10 MG [Xeljanz]", "type": "DRUG" }, { "name": "Placebo to match Tofacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2019-09-03", "completion_date": "2026-11-30", "has_results": false, "last_update_posted_date": "2024-11-25", "last_synced_at": "2026-09-28T14:14:28.602Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03681275" } ] }